Skip to main content
. 2021 Jun 23;12:600210. doi: 10.3389/fgene.2021.600210

TABLE 2.

51 benign or likely benign variants in RPGR from 101 unrelated families (based on NM_001034853).

Variants Exon Nucleotide Effect gnomAD No. of probands Diagnosis Novel or Evidence

change AF Hemi EA Hemi (reported) Known
Missense
1 ORF15 c.1910G>A p.S637N B N 0.055 23.6 NA NA NA NA 1(1) HM Known 3
2 ORF15 c.1930G>A p.V644M B N 0.004 9.241 NA NA NA NA 1 RP Novel 1, 3, 5
3 ORF15 c.1957G>A p.G653S B N 0.019 10.57 NA NA NA NA 1 BCD Novel 2, 3, 5
4 ORF15 c.1967A>T p.D656V B N 0.043 16.41 NA NA NA NA 1(1) HM Known 3
5 ORF15 c.2135A>G p.Q712R B N 0.038 0.077 9/157035 2 9/12249 2 8(1) N, HM, RB, ONH, G, HYP Known 2, 3, 4, 5, 6
6 ORF15 c.2200G>A p.E734K P N 0.04 18.53 6/117024 1 5/8773 1 5(1) G, NYS, HM Known 2, 3, 4, 5
7 ORF15 c.2342C>T p.A781V B N 0.082 5.756 11/126393 4 0/9010 0 1 RP Novel 3, 4
8 ORF15 c.2357A>C p.K786T B N 0.013 13.68 NA NA NA NA 1 Best Novel 2, 3, 5
9 ORF15 c.2606A>G p.E869G B N 0.062 14.86 25/40040 0 0/3847 0 1 RP Novel 3, 4
10 ORF15 c.2995G>T p.G999W P N 0.025 17.62 1/71397 0 1/7897 0 1 RP Novel 3, 4, 5
11 ORF15 c.3035A>G p.E1012G B N 0.031 12.1 5/110513 2 5/9144 2 2 RB, RP Novel 2, 3, 4, 5
12 ORF15 c.3088G>A p.G1030R B N 0.046 15.2 NA NA NA NA 1 RP Novel 1, 3, 5
13 ORF15 c.3122A>G p.E1041G B N 0.04 14.35 NA NA NA NA 2 LCA, HM Novel 1, 3
14 ORF15 c.3220G>A p.E1074K B N 0.034 14.59 3/181654 1 2/13859 1 1 G Novel 2, 3, 4
15 ORF15 c.3271A>T p.I1091L B N 0.006 10.61 NA NA NA NA 2 N, RB Novel 2, 3, 6
16 ORF15 c.3439C>G p.H1147D P N 0.257 24.1 NA NA NA NA 1 RP Novel 3
In-frame
1 ORF15 c.2360_2362del p.G787del / / / / 3/127259 0 3/9008 0 1 HM Novel 4
2 ORF15 c.2447_2461del p.G816_E820del / / / / 123/103374 16 2/7866 1 4(1) CORD, RP, RB, HM Known 2, 4
3 ORF15 c.2952_2954del p.E985del / / / / 2/52677 1 1/6728 0 1 LCA Novel 4
4 ORF15 c.3032_3043del p.G1011_E1014del / / / / 3/116321 0 1/9309 0 1 HM Novel 4
5 ORF15 c.3051_3053del p.E1018del / / / / 547/119184 118 1/9395 1 1 NYS Novel 4
6 ORF15 c.3105_3122delins p.E1037_E1041delins# / / / / NA NA NA NA 7 N, HM, RD, FEVR, RP Novel 1, 2, 6
7 ORF15 c.3123_3125del p.E1042del / / / / 25/191580 6 2/14266 0 2(1) RP Known 4
8 ORF15 c.3133_3135del p.E1045del / / / / 4/176793 3 0/13596 0 1 RP Novel NA
9 ORF15 c.3170_3172del p.R1057del / / / / 10/201586 5 1/14789 0 1 RP Novel 4
10 ORF15 c.3180_3182del p.E1066del / / / / 2/181016 0 0/13852 0 1 HM Novel NA
11 ORF15 c.3189_3191del p.E1066del / / / / 2/181292 0 1/13854 0 1 G Novel 2, 4
12 ORF15 c.3195_3197del p.E1066del / / / / 2/181292 0 1/13854 0 1 HM Novel 4
13 ORF15 c.3225_3227del p.E1076del / / / / 1/181925 0 0/13860 0 1 HM Novel NA
Exon1-14
1 1 c.7G>A p.E3K P N 0.127 22.2 NA NA NA NA 1 G Novel 2, 3
2 2 c.37G>A p.A13T D D 0.485 25.3 NA NA NA NA 1 FEVR Novel 2
3 2 c.112G>A p.V38I B N 0.051 0.066 NA NA NA NA 1 LD Novel 2, 3, 5
4 4 c.277G>T p.A93S D D 0.59 24.4 1/182876 1 1/13846 1 4 RD, HM, COD, CD Novel 1, 2, 4, 5
5 6 c.522A>T p.L174F D D 0.55 15.94 NA NA NA NA 1 N Novel 6
6 7 c.738C>G p.I246M P N 0.404 17.84 NA NA NA NA 1 HM Novel 3
7 8 c.782A>C p.N261T B N 0.19 7.487 4/180617 2 4/13651 2 4 N, RP, RD, HM Novel 2, 3, 4, 5, 6
8 7 c.727G>A p.E243K P N 0.33 23.1 NA NA NA NA 1 G Novel 2
9 10 c.1163C>T p.A388V B N 0.049 5.981 44/183213 14 0/13847 0 2 G, HM Novel 2, 3, 4
10 11 c.1270A>G p.M424V B D 0.12 6.942 3/182944 0 0/13818 0 1 PHPV Novel 2, 3
11 11 c.1282C>G p.L428V P N 0.129 14.6 35/204797 14 35/14807 14 8(1) G, HM, OA, RP, RD, RRD Known 2, 3, 4, 5
12 11 c.1331A>G p.N444S B N 0.012 0.002 2/183351 0 0/13858 0 1 RRD Novel 2, 3, 5
13 11 c.1367A>G p.Q456R B N 0.016 0.052 1704/205075 594 0/14852 0 1 G known 2, 3, 4
14 13 c.1519A>G p.S507G P D 0.046 22 4/164448 0 4/12070 0 2 LCA, G Novel 1, 2, 4
15 13 c.1561C>G p.Q521E B N 0.046 16.13 5/171108 3 5/12659 3 6 G, MC, RB, HYP, HM Novel 1, 2, 3, 4
16 14 c.1585A>G p.I529V B N 0.006 0.002 2/181278 0 1/13849 0 3 NYS, HM, LCA Novel 2, 3
17 14 c.1622A>G p.N541S B N 0.016 0.343 NA NA NA NA 1 RRD Novel 2, 3, 5
18 14 c.1628A>G p.D543G B N 0.011 4.167 NA NA NA NA 1 RP Novel 3
19 14 c.1630A>G p.S544G P N 0.049 19.15 2/182957 1 1/13858 0 3(1) N, G, HM Known 2, 3, 4, 6
20 14 c.1720A>G p.T574A B N 0.013 0.527 NA NA NA NA 1 LCA Novel 3, 5
21 14 c.1721C>T p.T574M B N 0.008 1.128 23/204508 9 1/14838 0 1 HM Novel 3, 4
22 10 c.1117_1119dupAAA p.K373dup / / / / 12/182610 6 12/13812 6 3 MD, HM, RB Novel 1, 2, 4

AF, allele frequency; CD, corneal degeneration; COD, cone dystrophy; CORD, cone-rod dystrophy; EA, East Asians; G, glaucoma; HM, high myopia; Hyp, Hypermetropia; LCA, Leber congenital amaurosis; LD, lens dislocation; MC, macular coloboma; MD, macular degeneration; N, normal; NA, not available; NYS, nystagmus; OA, ocular albinism; ONH, Optic nerve hypoplasia; PHPV, Persistent Hyperplastic Primary Vitreous; RB, retinoblastoma; RD, retinal diseases; RP, retinitis pigmentosa; RRD, Rhegmatogenous Retinal Detachment; /, not applicable; FEVR, familial exudative vitreoretinopathy; AGAAAGGGAAAAGGAGGG; #ArgGluLysGluGly; ()∮ Previously reported by our lab. 1, polyphen-2 HVAR; 2, PROVEAN; 3, REVEL; 4, CADD. gnomAD, genome aggregation database; HGMD, the Human Gene Mutation Database.

Evidence that variant is benign or likely benign: 1 = does not segregate with inherited eye diseases in one or more families (males with variants were unaffected); 2 = variant identified in one or more families with eye disease other than RP, CORD, COD, MD, or HM; 3 = at least two of four predicting tools are benign; 4 = MAF ≥ 4.7 × 10–5 in gnomAD database; 5 = identified other known IRD pathogenic variants; 6 = verified in controls.

All variants are not recorded in HGMD except the variant c.1630A>G.